Cita APA

Viktorsson, K., Shah, C., Juntti, T., Hååg, P., Zielinska-Chomej, K., Sierakowiak, A., . . . Ullén, A. (2016). Melphalan‐flufenamide is cytotoxic and potentiates treatment with chemotherapy and the Src inhibitor dasatinib in urothelial carcinoma. Mol Oncol.

Citación estilo Chicago

Viktorsson, Kristina, et al. "Melphalan‐flufenamide Is Cytotoxic and Potentiates Treatment With Chemotherapy and the Src Inhibitor Dasatinib in Urothelial Carcinoma." Mol Oncol 2016.

Cita MLA

Viktorsson, Kristina, et al. "Melphalan‐flufenamide Is Cytotoxic and Potentiates Treatment With Chemotherapy and the Src Inhibitor Dasatinib in Urothelial Carcinoma." Mol Oncol 2016.